PM Modi to launch covid-19 vaccination drive today; check out major updates

India will start its vaccination drive with vaccines developed by Oxford University- AstraZeneca produced locally by Serum Institute and indigenous vaccine of Bharat Biotech advanced in collaboration with Indian Council of Medical Research and National Institute of Virology.

PM Modi to launch covid-19 vaccination drive today; check out major updates
x

New Delhi: India is all set to kick-start world's largest covid-19 vaccination drive on Saturday, in a bid to get rid of the virus that has killed over 1,51,918 people, thrashed economy and has changed the life as we knew it.  Prime Minister Narendra Modi will inaugurate the vaccination programme at 10:30 am in the morning via video conferencing, the Prime Minister's Office has said in a statement released on Thursday. 


Prime Minister Narendra Modi also took to Twitter on Friday to share the details regarding the coronavirus vaccination inaugural event. Taking to Twitter, PM Modi wrote: "Tomorrow, January 16, India begins the pan-India rollout of Covid-19 Vaccination drive. The launch will take place at 10:30 AM tomorrow morning." 



Ahead of the historic day, Health Minister Harsh Vardhan had said that the step is  "probably the beginning of the end" of Covid-19. He had also taken to Twitter on Thursday to bust myths and rumours related to the vaccine in an ask me anything session. 


The inoculation process will start in 3600 sites across the country. In the first phase, the government plans to inoculate over 3 crore health care and frontline workers. Around 100 beneficiaries will be inoculated in one day at one site, as per the advisory released by the government. 


India will start its vaccination drive with vaccines developed by Oxford University- AstraZeneca produced locally by Serum Institute and indigenous vaccine of  Bharat Biotech advanced in collaboration with Indian Council of Medical Research and National Institute of Virology.


As per the reports, the beneficiaries will not have an option to choose between the two vaccines. However, Bharat Biotech will pay a compensation to the beneficiaries if they suffer any serious adverse event that is proven to be casually related to the vaccine. This comes in the light of continuous criticism of Bharat Biotech's covaxin which has not submitted late-stage clinical trial analysis which is required for a vaccine to be granted emergency authorisation. 


Meanwhile, India's overall covid-19  cases has breached 1.05 crore mark, however, the active cases in the country have fallen down in the last few months. India on Tuesday reported just 12k cases, which is country's lowest total in seven months. Meanwhile, the daily fatalities, too, have remained below 300 mark for two weeks now. 












Next Story